Dr Bruce Petrie b.r.petrie@rgu.ac.uk
Associate Professor
Dr Bruce Petrie b.r.petrie@rgu.ac.uk
Associate Professor
Medicines are used everyday by humans. However, they can be detrimental to aquatic life. Pharmaceuticals enter the environment following human excretion and transport through wastewater systems. The danger pharmaceuticals pose is location specific depending on the amount consumed and how much it is diluted and degraded in water. Identifying where pharmaceuticals pose the greatest danger is essential for putting intervening measures in place to protect the environment. Traditionally, the danger posed by pharmaceuticals is determined by measuring their concentration in water. This is very expensive and time consuming to cover a wide range of pharmaceuticals across a large geographical area. Alternatively, freely available prescription information can be used to predict pharmaceutical concentrations in water at different times of year and locations. However, previous attempts to predict pharmaceuticals in water have found poor comparisons with measured concentrations. This is because all factors influencing the final pharmaceutical concentration in water are not accounted for. Their degradation during wastewater transport is overlooked. This Fellowship will investigate how different pharmaceuticals degrade and change during wastewater transport.
Type of Project | Fellowship |
---|---|
Status | Project Complete |
Funder(s) | The Royal Society |
Value | £28,356.00 |
Project Dates | Oct 30, 2023 - Nov 1, 2024 |
Environmental risk assessment of human pharmaceuticals in Scottish marine waters; combining new exposure and effect driven monitoring approaches Mar 15, 2019 - Mar 14, 2020
Our oceans and seas are the final destination for pollutants present in wastewaters from households, hospitals and industry. It is now recognised that ‘dilution isn’t the solution’ and pollutants from land have a negative impact on marine life. Pol...
Read More about Environmental risk assessment of human pharmaceuticals in Scottish marine waters; combining new exposure and effect driven monitoring approaches.
Emerging Pollutants2 – Wastewater Microplastics as Vectors for Potent Drugs Jan 4, 2021 - Dec 31, 2021
It is estimated that more than 10 million tonnes of plastics enter our oceans annually. Plastic pieces less than 5mm in diameter, termed microplastics, travel far from their original source and are ingested by organisms. Wastewater effluents are a ma...
Read More about Emerging Pollutants2 – Wastewater Microplastics as Vectors for Potent Drugs.
Elimination at source of biocidal agents from fresh water environments by TiO2 photocatalysis Oct 1, 2020 - Sep 30, 2024
Herbicides and pesticides (i.e. biocides) are widely used world-wide. Many biocidal agents are persistent in the freshwater environment and are on the EU watchlist for priority and priority hazardous substances, as well as the Scottish Environmental...
Read More about Elimination at source of biocidal agents from fresh water environments by TiO2 photocatalysis.
Nationwide surveillance of antimicrobial resistance in the Scottish population by wastewater-based epidemiology Oct 1, 2023 - Sep 30, 2027
Antimicrobial resistance (AMR) is one of the most significant threats to global health we face today. The WHO outlined in their AMR Global Action Plan that surveillance of AMR is essential to strengthen our knowledge and evidence base, and for the de...
Read More about Nationwide surveillance of antimicrobial resistance in the Scottish population by wastewater-based epidemiology.
One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines Oct 1, 2023 - Sep 30, 2027
There is a need to reduce pollutants at source instead of relying on water treatment for their removal. The One Health Breakthrough Partnership is working to reduce pharmaceutical pollution entering the environment. This includes prescribing medicine...
Read More about One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines.
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search